The effect of epicardial adipose tissue thickness with irritable bowel syndrome.
暂无分享,去创建一个
[1] Kazuo Awai,et al. Association between epicardial adipose tissue volume and characteristics of non-calcified plaques assessed by coronary computed tomographic angiography. , 2012, International journal of cardiology.
[2] M. Camilleri,et al. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[3] G. Barbara,et al. Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome , 2012, Journal of clinical gastroenterology.
[4] E. Nagel,et al. Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. , 2012, International journal of cardiology.
[5] Lu-Yuan Lee,et al. Protease‐Activated Receptor 2 , 2012 .
[6] F. Shih,et al. Association of epicardial adipose tissue with coronary atherosclerosis is region-specific and independent of conventional risk factors and intra-abdominal adiposity. , 2011, Atherosclerosis.
[7] A. Stillman,et al. EPICARDIAL ADIPOSE TISSUE AND CORONARY ARTERY PLAQUE CHARACTERISTICS , 2010 .
[8] H. Willens,et al. Echocardiographic epicardial fat: a review of research and clinical applications. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[9] L. Sade,et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[10] D. Santini,et al. Mucosal Immune Activation in Irritable Bowel Syndrome: Gender-Dependence and Association With Digestive Symptoms , 2009, The American Journal of Gastroenterology.
[11] E. Cereda,et al. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[12] F. Barreau,et al. Long-term alterations of colonic nerve–mast cell interactions induced by neonatal maternal deprivation in rats , 2008, Gut.
[13] H. Sacks,et al. Human epicardial adipose tissue: a review. , 2007, American heart journal.
[14] F. Casellas,et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum , 2006, Gut.
[15] G. Barbara. Mucosal Barrier Defects in Irritable Bowel Syndrome. Who Left the Door Open? , 2006, The American Journal of Gastroenterology.
[16] P. Scully,et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? , 2006, Gastroenterology.
[17] D. Santini,et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. , 2004, Gastroenterology.
[18] F. Leonetti,et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. , 2003, The Journal of clinical endocrinology and metabolism.
[19] H. Yatsuya,et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state , 2003, International Journal of Obesity.
[20] F. Leonetti,et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. , 2003, Obesity research.
[21] D. Drossman,et al. AGA technical review on irritable bowel syndrome. , 2002, Gastroenterology.
[22] B. Nyberg,et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. , 2002, Gastroenterology.
[23] Wangxue Chen,et al. Activation of the mucosal immune system in irritable bowel syndrome. , 2002, Gastroenterology.
[24] J. Takasu,et al. Pericardial fat accumulation in men as a risk factor for coronary artery disease. , 2001, Atherosclerosis.
[25] C. O'Morain,et al. Increased mast cells in the irritable bowel syndrome , 2000, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[26] G. Andrews,et al. Evidence of a Genetic Contribution to Functional Bowel Disorder , 1998, American Journal of Gastroenterology.
[27] A. Weston,et al. Terminal ileal mucosal mast cells in irritable bowel syndrome , 1993, Digestive Diseases and Sciences.
[28] Gao Xiuying. Association of epicardial adipose tissue volume with coronary artery atherosclerosis and left ventricular diastolic function , 2012 .
[29] N. Talley. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity , 2009 .
[30] Stomach , 2006, The American Journal of Gastroenterology.
[31] Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. , 2006, Journal of gastrointestinal and liver diseases : JGLD.
[32] C. Pond,et al. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. , 1989, Comparative biochemistry and physiology. B, Comparative biochemistry.